Goldman Sachs
OCS icon

Goldman Sachs’s Oculis Holding OCS Stock Holding History

Goldman Sachs’s Portfolio OCS Stock Details OCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
+67,753
New +$1.79M ﹤0.01% 4633

Other funds holding OCS

EFM
EQT Fund Management Luxembourg $1.02B AUM
GL
Gildi lifeyrissjodur Reykjavik $197M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs's OCS Position: Q1 2026 in Review

Goldman Sachs opened a new position in Oculis Holding (OCS) in Q1 2026: 67,753 shares worth $1.8M. The stake represents ﹤0.01% of the portfolio and ranks #4633 among its holdings.

57 funds tracked by Wall St. Rank hold OCS as of Q1 2026.

  • Goldman Sachs held 67,753 shares of Oculis Holding worth $1.8M as of Q1 2026.
  • Oculis Holding was a new Goldman Sachs position in Q1 2026.
  • Oculis Holding made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4633 holding.
  • 57 funds tracked by Wall St. Rank held Oculis Holding as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.